165 related articles for article (PubMed ID: 35177543)
1. PET/MR Imaging in Evaluating Treatment Failure of Head and Neck Malignancies: A Neck Imaging Reporting and Data System-Based Study.
Patel LD; Bridgham K; Ciriello J; Almardawi R; Leon J; Hostetter J; Yazbek S; Raghavan P
AJNR Am J Neuroradiol; 2022 Mar; 43(3):435-441. PubMed ID: 35177543
[TBL] [Abstract][Full Text] [Related]
2. Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.
Partovi S; Kohan A; Vercher-Conejero JL; Rubbert C; Margevicius S; Schluchter MD; Gaeta C; Faulhaber P; Robbin MR
AJNR Am J Neuroradiol; 2014 Oct; 35(10):1970-5. PubMed ID: 24924545
[TBL] [Abstract][Full Text] [Related]
3. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
4. Are Gadolinium-Enhanced MR Sequences Needed in Simultaneous
Pyatigorskaya N; De Laroche R; Bera G; Giron A; Bertolus C; Herve G; Chambenois E; Bergeret S; Dormont D; Amor-Sahli M; Kas A
AJNR Am J Neuroradiol; 2020 Oct; 41(10):1888-1896. PubMed ID: 32972956
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?
Kuhn FP; Hüllner M; Mader CE; Kastrinidis N; Huber GF; von Schulthess GK; Kollias S; Veit-Haibach P
J Nucl Med; 2014 Apr; 55(4):551-8. PubMed ID: 24491410
[TBL] [Abstract][Full Text] [Related]
6. Detection of loco-regional recurrence in malignant head and neck tumors: a comparison of CT, MRI, and FDG PET-CT.
Kim ES; Yoon DY; Moon JY; Baek S; Han YM; Seo YL; Yun EJ
Acta Radiol; 2019 Feb; 60(2):186-195. PubMed ID: 29754496
[TBL] [Abstract][Full Text] [Related]
7. Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
Wangaryattawanich P; Branstetter BF; Ly JD; Duvvuri U; Heron DE; Rath TJ
AJNR Am J Neuroradiol; 2020 Jun; 41(6):1070-1075. PubMed ID: 32467187
[TBL] [Abstract][Full Text] [Related]
8. FDG PET/MR for lymph node staging in head and neck cancer.
Platzek I; Beuthien-Baumann B; Schneider M; Gudziol V; Kitzler HH; Maus J; Schramm G; Popp M; Laniado M; Kotzerke J; van den Hoff J
Eur J Radiol; 2014 Jul; 83(7):1163-1168. PubMed ID: 24746792
[TBL] [Abstract][Full Text] [Related]
9. (18)F-Fluorodeoxyglucose PET/MR Imaging in Head and Neck Cancer.
Platzek I
PET Clin; 2016 Oct; 11(4):375-86. PubMed ID: 27593244
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous PET/MR head-neck cancer imaging: Preliminary clinical experience and multiparametric evaluation.
Covello M; Cavaliere C; Aiello M; Cianelli MS; Mesolella M; Iorio B; Rossi A; Nicolai E
Eur J Radiol; 2015 Jul; 84(7):1269-76. PubMed ID: 25958189
[TBL] [Abstract][Full Text] [Related]
11. PET+MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+MR system.
Sekine T; de Galiza Barbosa F; Kuhn FP; Burger IA; Stolzmann P; Huber GF; Kollias SS; von Schulthess GK; Veit-Haibach P; Huellner MW
Clin Imaging; 2017; 42():232-239. PubMed ID: 28129606
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma.
Wong WL; Chevretton EB; McGurk M; Hussain K; Davis J; Beaney R; Baddeley H; Tierney P; Maisey M
Clin Otolaryngol Allied Sci; 1997 Jun; 22(3):209-14. PubMed ID: 9222623
[TBL] [Abstract][Full Text] [Related]
13. Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.
Marcus C; Ciarallo A; Tahari AK; Mena E; Koch W; Wahl RL; Kiess AP; Kang H; Subramaniam RM
J Nucl Med; 2014 Sep; 55(9):1411-6. PubMed ID: 24947059
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
Kubota K; Yokoyama J; Yamaguchi K; Ono S; Qureshy A; Itoh M; Fukuda H
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):590-5. PubMed ID: 14722678
[TBL] [Abstract][Full Text] [Related]
15.
Wong ET; Dmytriw AA; Yu E; Waldron J; Lu L; Fazelzad R; de Almeida JR; Veit-Haibach P; O'Sullivan B; Xu W; Huang SH
Head Neck; 2019 Feb; 41(2):551-561. PubMed ID: 30456825
[TBL] [Abstract][Full Text] [Related]
16. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of image fusion from MR and PET in patients with head and neck cancer.
Nakamoto Y; Tamai K; Saga T; Higashi T; Hara T; Suga T; Koyama T; Togashi K
Mol Imaging Biol; 2009; 11(1):46-53. PubMed ID: 18769975
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
[TBL] [Abstract][Full Text] [Related]
20. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
